My Blog
Business

Microsoft drops after UBS analysts say company faces cloud weakness


A sign for Microsoft Corp. at the company’s office in the central business district of Lisbon, Portugal, on Tuesday, Dec. 27, 2022.

Zed Jameson | Bloomberg | Getty Images

Microsoft shares closed down 4% on Wednesday while the broader tech market rallied after analysts at UBS said the software company faces weakness, particularly in the cloud.

Analyst Karl Keirstead downgraded Microsoft to neutral from buy, writing that the latest round of field checks into the business lowered the bank’s confidence in the stock. Keirstead pointed to concerns at Azure, Microsoft’s cloud computing platform, and Office 365, the company’s family of productivity software.

The analyst said Office 365, which has been a “remarkably steady machine of late,” could see slower revenue growth in 2023, while Azure is entering a “steep growth deceleration” that could be worse in 2023 and 2024 than investors are expecting. 

Microsoft provides year-over-year growth for Azure and other cloud services but doesn’t give a dollar figure, nor does it specify how much of the growth comes just from Azure. The Azure and other cloud services segment also includes, among other things, enterprise mobility and security, or EMS, tools that can be sold separately.

Cloud rival Google put together an estimate of Microsoft’s Azure business, based on a leaked Microsoft document and some extrapolation of other market data. The Google analysis, which CNBC viewed last month, shows Azure ending the 2022 fiscal year with an operating loss of almost $3 billion, narrowing from a loss of more than $5 billion the prior year.

Other tech stocks rose Wednesday, with Apple, Tesla and Meta closing up between 1% and 5%.

— CNBC’s Michael Bloom contributed to this report.

Related posts

Peter Thiel’s ‘sociopaths’ know one thing he does not

newsconquest

Tequila may just overtake vodka as The united states’s peak liquor as gross sales increase

newsconquest

U.S. investigating Meta for role in illicit drug sales, WSJ reports

newsconquest

Leave a Comment